Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 55, Issue 5, Pages 999-1006
Publisher
Informa UK Limited
Online
2013-07-26
DOI
10.3109/10428194.2013.828354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphoinositide 3’-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia.
- (2015) Oncotarget
- CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL
- (2013) M. Binder et al. BLOOD
- Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells
- (2013) C. Zwick et al. BLOOD
- Biology of Chronic Lymphocytic Leukemia in Different Microenvironments
- (2013) Yair Herishanu et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
- (2013) Satiro N De Oliveira et al. Journal of Translational Medicine
- Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies
- (2013) K Matlawska-Wasowska et al. LEUKEMIA
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
- (2013) Bipulendu Jena et al. PLoS One
- CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
- (2013) Marco L. Davila et al. PLoS One
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Self-antigen recognition by follicular lymphoma B-cell receptors
- (2012) K. L. Sachen et al. BLOOD
- Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development
- (2012) S. Simmons et al. BLOOD
- Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
- (2012) M. S. Topp et al. BLOOD
- Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow
- (2012) K. Boucher et al. CLINICAL CANCER RESEARCH
- Regulation of Humoral Immunity by Complement
- (2012) Michael C. Carroll et al. IMMUNITY
- Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes
- (2012) Ganna A. Liubchenko et al. JOURNAL OF AUTOIMMUNITY
- CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis
- (2012) Elaine Y. Chung et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Multidose-Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-Cell Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Divergence in CD19-Mediated Signaling Unfolds Intraclonal Diversity in Chronic Lymphocytic Leukemia, Which Correlates with Disease Progression
- (2012) Y. Herishanu et al. JOURNAL OF IMMUNOLOGY
- IL-10-Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
- (2012) A. Das et al. JOURNAL OF IMMUNOLOGY
- A c-Myc and Surface CD19 Signaling Amplification Loop Promotes B Cell Lymphoma Development and Progression in Mice
- (2012) J. C. Poe et al. JOURNAL OF IMMUNOLOGY
- CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
- (2012) N Hosen et al. LEUKEMIA
- CD19−CD45low/−CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
- (2012) D Kim et al. LEUKEMIA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations
- (2012) Jawad Francis et al. LEUKEMIA & LYMPHOMA
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
- (2011) J. Hoellenriegel et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
- (2011) M C Béné et al. LEUKEMIA
- A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254
- (2011) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children
- (2010) Barry Pizer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency
- (2010) Nicolas Vince et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
- (2010) Menno C. van Zelm et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
- (2010) R. Watanabe et al. JOURNAL OF IMMUNOLOGY
- Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
- (2010) R Handgretinger et al. LEUKEMIA
- Mixed-phenotype acute leukemia: historical overview and a new definition
- (2010) O K Weinberg et al. LEUKEMIA
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5
- (2010) K Walter et al. ONCOGENE
- CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
- (2009) F. T. Awan et al. BLOOD
- A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
- (2009) Pina M. Cardarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The impact of Fc engineering on an anti-CD19 antibody: increased Fc receptor affinity enhances B-cell clearing in nonhuman primates
- (2008) J. Zalevsky et al. BLOOD
- Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
- (2008) H. M. Horton et al. CANCER RESEARCH
- Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation
- (2008) Kathryn Rizzo et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
- (2008) Gema Mateo et al. JOURNAL OF CLINICAL ONCOLOGY
- Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
- (2008) P. Ghia et al. JOURNAL OF INTERNAL MEDICINE
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- Germinal center structure and function: Lessons from CD19
- (2008) Robert H. Carter et al. SEMINARS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now